Vylor Inc.: BMO initiates coverage with outperform rating; target price $85
VYLR•BMO initiated coverage of Vylor Inc. with an outperform rating and an $85 target price.
Related News
Syndax announces topline results from Maxpire Phase 2 trial of axatilimab in idiopathic pulmonary fibrosis
SNDX•
US AI testing agency officials reportedly plan to move to White House
XLK•
Humana sets third-quarter results release and earnings call
HUM•
Howard Hughes Holdings updates financial calendar with Q3 earnings release, conference call schedule
HHH•
Par Pacific updates financial calendar with third-quarter earnings release, investor call schedule
PARR•